Mobile and Wireless Sales Force Strategies under the spotlight
27 April 2006, NetworkPharma Ltd, Oxford, UK have published the latest in their KeywordPharma series of brand new conference reports intended for individuals working in and around the global pharmaceutical industry.
Mobile and Wireless Sales Force Strategies; in-depth report from the eyeforpharma conference, Barcelona, 14-15 March 2006 is now available for purchase.
Mobile communication is emerging as a core part of the pharmaceutical sales process. Doctors are no longer strangers to technology, with devices such as PDAs (personal data assistants) playing a key role in conversations between representatives and physicians.
Ten years ago, technology was an enabling service, with the sales force its client. Now, increasingly, technology is not only setting the agenda, it is also setting the strategy. Technology projects tend to be driven more by the technology available than by the business needs that must be met. Dominant technologies such as Google, Skype and BlackBerry have now taken over the strategy.
So, how does the pharmaceutical industry drive, maximise and, just as importantly, maintain mobile adoption? What does it use mobile technology for? And which devices will best serve its needs?
The eyeforpharma conference on Mobile and Wireless Sales Force Strategies, held in Barcelona on 14-15 March 2006, addressed these critical issues, with case studies from leading European players attempting to provide answers. This Conference Insights review looks at the most pertinent factors driving mobile communication and its impact on sales force strategy in pharmaceuticals.
The author, John Hosken, said: "Interestingly, mobile is not being used for what an outside observer might think was the primary purpose of representatives: to persuade doctors to prescribe more of their company’s products. Mobile is only - so far - being used to keep track of who, when, how often and for how long representatives visit, not for what they say when they finally see a doctor."
Peter Llewellyn, Managing Director of NetworkPharma Ltd commented, "We are delighted to see this valuable new series of expert reports fulfilling its aim of providing real value to so many individuals working within and around the pharmaceutical industry "
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the author
John Hosken has been closely involved in writing about, planning and implementing technology for the pharmaceutical industry for the past decade. After a career in financial and consultancy marketing, he joined Merck in 1997 as one of the pharmaceutical industry’s first internet strategy managers. He helped the company to get involved in using the web to market to doctors in a wide range of countries, moving to Acurian to develop its franchise in the clinical trials online recruitment market, and then held a range of pharmaceutical marketing posts in various agencies. He has been writing on pharmaceutical marketing and technology topics for Pharmafocus since 2002.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
